Overview

Efficacy and Safety Study of Bimatoprost Sustained-Release (SR) in Participants With Open-angle Glaucoma or Ocular Hypertension

Status:
Completed

Trial end date:
2019-07-19

Target enrollment:

Participant gender:

Summary

This study will evaluate the efficacy and safety of bimatoprost SR in participants with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.

Phase:

Phase 3

Details

Lead Sponsor:

Allergan

Treatments:

Bimatoprost
Timolol